Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Payagastron is a homeopathic complex medicine developed by Weber & Weber Biologische Arzneimittel for the treatment of various stomach disorders, including gastritis, heartburn, and bloating. It is formulated as oral drops containing a combination of homeopathic dilutions: sulfuric acid (Acidum sulfuricum), belladonna (Atropa bella-donna), bismuth subnitrate (Bismuthum subnitricum), vegetable charcoal (Carbo vegetabilis), and magnesium trisilicate (Magnesium trisilicicum). These components are traditionally used in homeopathy to alleviate gastric mucosal irritation, reduce spasms via muscarinic receptor antagonism, and improve digestive function. As a natural medicine, it aims to stimulate the body's self-healing processes to resolve functional gastrointestinal complaints.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Payagastron.